Science Explorer Back to mapMap
Discussion
Nonprofit · St. Gallen · Switzerland

St. Gallen Oncology Conferences

Research works
7
▼ 75% vs 2018-21
Citations
278
42.1 per fractional work
Top-10% rate
3.7%
all institutions 10.0%
Open access
66%
world 40%
International
39%
world 18%

Not ranked overall: St. Gallen Oncology Conferences is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does St. Gallen Oncology Conferences work in?

In all years, 74% of research at St. Gallen Oncology Conferences is in Health Sciences, 25% in Life Sciences. Its largest fields are Medicine (74%), Biochemistry, Genetics and Molecular Biology (17%), Immunology and Microbiology (5%). It does 1.7× the world's share of Health Sciences.

Health Sciences: 5 fractional works · 73.7% of its workMedicine: 5 fractional works · 73.7% of its workOncology: 1 fractional works · 19.7% of its workPulmonary and Respiratory Medicine: 1 fractional works · 18.9% of its workRadiology, Nuclear Medicine and Imaging: 0 fractional works · 7.6% of its workGenetics: 0 fractional works · 5.6% of its workSurgery: 0 fractional works · 4.5% of its workEpidemiology: 0 fractional works · 3.8% of its workOphthalmology: 0 fractional works · 2.6% of its workPharmacology: 0 fractional works · 2.6% of its workHematology: 0 fractional works · 2.3% of its workPathology and Forensic Medicine: 0 fractional works · 1.7% of its workReproductive Medicine: 0 fractional works · 1.2% of its workGeriatrics and Gerontology: 0 fractional works · 0.9% of its workPsychiatry and Mental health: 0 fractional works · 0.6% of its workNeurology: 0 fractional works · 0.5% of its workPhysiology: 0 fractional works · 0.5% of its workPublic Health, Environmental and Occupational Health: 0 fractional works · 0.5% of its workFamily Practice: 0 fractional works · 0.3% of its workPediatrics, Perinatology and Child Health: 0 fractional works · 0.3% of its workLife Sciences: 2 fractional works · 24.5% of its workBiochemistry, Genetics and Molecular Biology: 1 fractional works · 17.4% of its workMolecular Biology: 1 fractional works · 9.2% of its workCancer Research: 0 fractional works · 7.1% of its workCell Biology: 0 fractional works · 0.8% of its workBiotechnology: 0 fractional works · 0.5% of its workImmunology and Microbiology: 0 fractional works · 4.5% of its workImmunology: 0 fractional works · 4.5% of its workNeuroscience: 0 fractional works · 2.6% of its workNeurology: 0 fractional works · 2.6% of its workPhysical Sciences: 0 fractional works · 1.2% of its workChemistry: 0 fractional works · 1.2% of its workOrganic Chemistry: 0 fractional works · 1.2% of its workSocial Sciences: 0 fractional works · 0.6% of its workEconomics, Econometrics and Finance: 0 fractional works · 0.6% of its workEconomics and Econometrics: 0 fractional works · 0.6% of its workALL ITS WORKSt. GallenOncology…7fractional works, all years
Life Sciences25%Physical Sciences1%Health Sciences74%Social Sciences1%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 6 fields, with their numbers
    1. Medicine573.7%
    1. Biochemistry, Genetics and Molecular Biology117.4%
    2. Immunology and Microbiology04.5%
    3. Neuroscience02.6%
    1. Chemistry01.2%
    1. Economics, Econometrics and Finance00.6%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

What are the most cited papers from St. Gallen Oncology Conferences?

The most cited paper from St. Gallen Oncology Conferences is "Customizing local and systemic therapies for women with early breast cancer: the St. Gallen International Consensus Guidelines for treatment of early breast cancer 2021" (Harold J. Burstein et al., 2021), with 842 citations. Next come "The global, regional, and national burden of cancer, 1990–2023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023" (330) and "Clinical multidrug resistance in cancer: A multifactorial problem" (178).

Most cited papers
#PaperReleasedCitations
1 Customizing local and systemic therapies for women with early breast cancer: the St. Gallen International Consensus Guidelines for treatment of early breast cancer 2021 Harold J. Burstein et al. · Annals of Oncology Open access 6 Jul 2021 842
2 The global, regional, and national burden of cancer, 1990–2023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023 Lisa M Force et al. · The Lancet Open access1,377 authors 25 Sep 2025 330
3 Clinical multidrug resistance in cancer: A multifactorial problem Manfred Lehnert · European Journal of Cancer Jun 1996 178
4 The p97 Inhibitor CB-5083 Is a Unique Disrupter of Protein Homeostasis in Models of Multiple Myeloma Ronan Le Moigne et al. · Molecular Cancer Therapeutics 6 Sep 2017 117
5 Characterization of nivolumab-associated skin reactions in patients with metastatic non-small cell lung cancer Omar Hasan Ali, Stefan Diem, Eva Markert et al. · OncoImmunology Open access 19 Sep 2016 117
All 27 most cited papers, with filters and sorting

Which research topics does St. Gallen Oncology Conferences publish most on?

By volume in 2022-now: Acute Ischemic Stroke Management, Cancer Research and Treatments, Bipolar Disorder and Treatment and Intracerebral and Subarachnoid Hemorrhage Research.

  1. 1 Acute Ischemic Stroke Management Epidemiology 0 works
  2. 2 Cancer Research and Treatments Biotechnology 0 works
  3. 3 Bipolar Disorder and Treatment Psychiatry and Mental health 0 works
  4. 4 Intracerebral and Subarachnoid Hemorrhage Research Neurology 0 works
  5. 5 Medication Adherence and Compliance Family Practice 0 works
  6. 6 Traumatic Brain Injury and Neurovascular Disturbances Neurology 0 works
  7. 7 Occupational and environmental lung diseases Pulmonary and Respiratory Medicine 0 works
  8. 8 Colorectal Cancer Treatments and Studies Oncology 0 works
  9. 9 Pleural and Pulmonary Diseases Pulmonary and Respiratory Medicine 0 works
  10. 10 Frailty in Older Adults Geriatrics and Gerontology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available65.6%not open34.4%

World: 40% of research is openly available.

with international co-authors39.1%domestic only60.9%

World: 18% is written across borders.

How has St. Gallen Oncology Conferences's research output changed?

Output in 2022-2025 was 75% lower than in 2018-2021.

still counting200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is St. Gallen Oncology Conferences as a percentage of every work published that year, 0.0000023% in 2022.

still counting0.000050%0.00010%0.00015%St. Gallen Oncology Conferences0.0000017% in 2025200020102020

Fractional works of St. Gallen Oncology Conferences over all fractional works that year. How the balance of science has shifted.

Other research institutions in St. Gallen

All research institutions in St. Gallen

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about St. Gallen Oncology Conferences. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.